UnitedHealthcare signal is displayed at its workplace constructing in Minnetonka, Minnesota, U.S., Dec. 11, 2025.
Tim Evans | Reuters
UnitedHealth Group on Tuesday posted first-quarter earnings that topped estimates and hiked its 2026 revenue outlook, as the corporate higher manages excessive medical prices and streamlines its operations.
The nation’s largest personal insurer stated it expects 2026 adjusted earnings of greater than $18.25 per share, up from a earlier outlook of greater than $17.75 per share. UnitedHealth is sustaining its full-year income steering of higher than $439 billion, which the corporate stated in January displays “right-sizing throughout the enterprise.”
Here is what the corporate reported for the first quarter in contrast with what Wall Avenue was anticipating, primarily based on a survey of analysts by LSEG:
- Earnings per share: $7.23 adjusted vs. $6.57 anticipated
- Income: $111.72 billion vs. $109.57 billion anticipated
Shares jumped about 8% in morning buying and selling Tuesday.
UnitedHealth is banking on a brand new management staff to hold out a turnaround plan. The technique includes shrinking membership, promoting the U.Okay. enterprise of its Optum health-care unit, closely investing in synthetic intelligence, streamlining entry to care and rising transparency to revive profitability — together with the corporate’s repute — after a sequence of hurdles during the last two years.
The corporate posted first-quarter internet earnings of $6.28 billion, or $6.90 per share, in contrast with $6.29 billion, or $6.85 per share, in the identical interval a 12 months in the past. Excluding objects like enterprise divestitures, restructuring and the anticipated discount of reserves for unprofitable contracts, UnitedHealth earned $7.23 per share.
Income climbed to $111.72 billion from $109.58 billion within the prior-year quarter. The corporate’s insurer, UnitedHealthcare, and Optum each topped analysts’ gross sales estimates for the quarter, based on StreetAccount.
Notably, UnitedHealth seems to have a greater deal with on larger medical prices – a difficulty that has dogged the broader insurance coverage business for greater than two years. Insurers, significantly people who privately run Medicare plans, have been pinched by an inflow of individuals searching for care they delayed post-pandemic and high-cost specialty medicine like GLP-1s, amongst different elements.
UnitedHealth’s medical profit ratio — a measure of complete medical bills paid relative to premiums collected — got here in at 83.9% for the primary quarter. That is an enchancment from the 84.8% reported within the year-earlier interval. A decrease ratio usually signifies that the corporate collected extra in premiums than it paid out in advantages, leading to larger profitability.
Analysts have been anticipating a ratio of 85.5% for the quarter, based on StreetAccount.
In a launch, UnitedHealth stated the first-quarter ratio displays its robust administration of medical prices and the discharge of beforehand set-aside funds for unprofitable Optum contracts. However that enchancment was partially offset by “constantly elevated” medical prices, the corporate famous.
“We’re persevering with to assist simplify and modernize well being take care of the folks and care suppliers we serve, bringing higher worth, affordability, transparency and connectivity,” UnitedHealth CEO Stephen Hemsley stated within the launch.
The outcomes come simply weeks after the Trump administration finalized a 2027 cost fee enhance to Medicare Benefit plans that was far larger than initially proposed, in a lift to UnitedHealth and different well being insurer shares.
Questions round weight problems drug protection
The corporate additionally raised contemporary questions on insurers’ participation within the Trump administration’s plans for Medicare protection of weight problems medicine subsequent 12 months.
Insurers had till Monday to inform the federal authorities whether or not they would take part this system, which might cowl well-liked GLP-1 therapies from Eli Lilly and Novo Nordisk. Whereas UnitedHealth, the most important supplier of privately run Medicare Benefit plans, has not explicitly stated whether or not it is going to take part, its willingness to take action is vital for this system to maneuver ahead.
“We might prefer to discover a path, sure, there on protection over time, however there are some notable challenges and excellent questions with the at present deliberate construction,” stated Bobby Hunter, the top of UnitedHealth’s authorities packages, on the corporate’s earnings name. “So, we’re nonetheless working by that course of internally and we stay up for persevering with the dialogue with CMS.”
A Division of Well being and Human Companies spokesperson didn’t instantly reply to a request for remark.
